This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Influenza A H12N1 Hemagglutinin HA1 Subunit (HA1), C-His
Product Overview
BioVenic's Recombinant Influenza A H12N1 Hemagglutinin HA1 Subunit (HA1), C-His is a recombinant protein expressed from HEK293 Cells. Its predicted molecular weight is 38.3 kDa. The purity is>95% (SDS-PAGE). The endotoxin level is <1 EU/μg (LAL).
Specifications
Target Information
The IAV subtype H12 was initially identified in Canada in 1976, with the first isolation of the H12N1 virus from a mallard duck in 1983. The hemagglutinin (HA) protein, a crucial glycoprotein of the influenza virus, plays an essential role in the early stages of viral infection. The HA1 subunit, which contains a receptor binding site, facilitates the virus's attachment to specific sialyl sugar chains on the host cell surface.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store for 4 weeks at 2-8°C, for 12 months at -20°C or -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.